Persistence of an [E1-, polymerase-] adenovirus vector despite transduction of a neoantigen into immune-competent mice

Human Gene Therapy

Volumn 10, Issue 3, 1999, Pages 355-364

  Hu, Huimin ^a   Serra, Delila ^a   Amalfitano, Andrea ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; LIVER; LIVER TOXICITY; MOUSE; NONHUMAN; VIRUS MUTANT;

ADENOVIRIDAE; ANIMALS; ANTIGENS; ASPARTATE AMINOTRANSFERASES; BETA-GALACTOSIDASE; CHROMOGENIC COMPOUNDS; DNA; GALACTOSIDES; GENETIC VECTORS; HUMANS; IMMUNE SYSTEM; INDOLES; LIVER; MICE; RNA; TIME FACTORS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; BACTERIA (MICROORGANISMS); DNA VIRUSES;

EID: 0033540652     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950018805     Document Type: Article

References (47)

1. AMALFITANO, A., and CHAMBERLAIN, J.S. (1996). The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve 19, 1549-1553.
2. AMALFITANO, A., and CHAMBERLAIN, J.S. (1997). Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins - implications for gene therapy. Gene Ther. 4, 258-263.
3. AMALFITANO, A., BEGY, C.R., and CHAMBERLAIN, J.S. (1996). Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. U.S.A. 93, 3352-3356.
4. AMALFITANO, A., HAUSER, M.A., HU, H., SERRA, D., BEGY, C.R., and CHAMBERLAIN, J.S. (1998). Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted. J. Virol. 72, 926-933.
5. ARMENTANO, D., ZABNER, J., SACKS, C., SOOKDEO, C.C., SMITH, M.P., STGEORGE, J.A., WADSWORTH, S.C., SMITH, A.E., and GREGORY, R.J. (1997). Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71, 2408-2416.
6. ASKARI, F.K., HITOMI, Y., MAO, M., and WILSON, J.M. (1996). Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Gene Ther. 3, 381-388.
7. BARR, D., TUBB, J., FERGUSON, D., SCARIA, A., LIEBER, A., WILSON, C., PERKINS, J., and KAY, M.A. (1995). Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: Comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2, 151-155.
8. BATTS, K.P., and LUDWIG, J. (1995). Chronic hepatitis. An update on terminology and reporting. Am. J. Surg. Pathol. 19(2), 1409-1417.
9. BROUGH, D.E., HSU, C., KULESA, V.A., LEE, G.M., CANTOLUPO, L.J., LIZONOVA, A., and KOVESDI, I. (1997). Activation of transgene expression by early region 4 is responsible for a high level of persistent transgene expression from adenovirus vectors in vivo. J. Virol. 71, 9206-9213.
10. CHEN, H.H., MACK, L.M., KELLY, R., ONTELL, M., KOCHANEK, S., and CLEMENS, P.R. (1997). Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. U.S.A. 94, 1645-1650.
11. CLEMENS, P.R., KOCHANEK, S., SUNADA, Y., CHAN, S., CHEN, H.H., CAMPBELL, K.P., and CASKEY, C.T. (1996). In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3, 965-972.
12. CLESHAM, G.J., BROWNE, H., EFSTATHIOU, S., and WEISSBERG, P.L. (1996). Enhancer stimulation unmasks latent gene transfer after adenovirus-mediated gene delivery into human vascular smooth muscle cells. Circ. Res. 79, 1188-1195.
13. CLESHAM, G.J., ADAM, P.J., PROUDFOOT, D., FLYNN, P.D., EFSTATHIOU, S., and WEISSBERG, P.L. (1998). High adenoviral loads stimulate NF-kappa-B-dependent gene expression in human vascular smooth muscle cells. Gene Ther. 5, 174-180.
14. DECONINCK, N., RAGOT, T., MARECHAL, G., PERRICAUDET, M., and GILLIS, J.M. (1996). Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. U.S.A. 93, 3570-3574.
15. DECONINCK, N., TINSLEY, J., DEBACKER, F., FISHER, R., KAHN, D., PHELPS, S., DAVIES, K., and GILLIS, J.M. (1997). Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med. 3, 1216-1221.
16. DEDIEU, J.F., VIGNE, E., TORRENT, C., JULLIEN, C., MAHFOUZ, I., CAILLAUD, J.M., AUBAILLY, N., ORSINI, C., GUILLAUME, J.M., OPOLOW, P., DELAERE, P., PERRICAUDET, M., and YEH, P. (1997). Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. J. Virol. 71, 4626-4637.
17. DEMATTEO, R.P., MARKMANN, J.F., KOZARSKY, K.F., BARKER, C.F., and RAPER, S.E. (1996). Prolongation of adenoviral transgene expression in mouse liver by T lymphocyte subset depletion. Gene Ther. 3, 4-12.
18. FANG, B., EISENSMITH, R.C., WANG, H., KAY, M.A., CROSS, R.E., LANDEN, C.N., GORDON, G., BELLINGER, D.A., READ, M.S., HU, P.C., BRINKHOUS, K.M., and WOO, S.L.C. (1995). Gene therapy for hemophilia B: Host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression. Hum. Gene Ther. 6, 1039-1044.
19. GAO, G.P., YANG, Y.P., and WILSON, J.M. (1996). Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70, 8934-8943.
20. GUO, Z.S., WANG, L.H., EISENSMITH, R.C., and WOO, S.L. (1996). Evaluation of promoter strength for hepatic gene expression in vivo following adenovirus-mediated gene transfer. Gene Ther. 3, 802-810.
21. HARMS, J.S., and SPLITTER, G.A. (1995). Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6, 1291-1297.
22. HOWELL, J.M., LOCHMULLER, H., OHARA, A., FLETCHER, S., KAKULAS, B.A., MASSIE, B., NALBANTOGLU, J., and KARPATI, G. (1998). High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: Prolongation of expression with immunosuppression. Hum. Gene Ther. 9, 629-634.
23. ILAN, Y., JONA, V.K., SENGUPTA, K., DAVIDSON, A., HORWITZ, M.S., ROYCHOWDHURY, N., and ROYCHOWDHURY, J. (1997). Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat. Hepatology 26, 949-956.
24. JOOSS, K., YANG, Y., FISHER, K.J., and WILSON, J.M. (1998). Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212-4223.
25. KAPLAN, J.M., ARMENTANO, D., SPARER, T.E., WYNN, S.G., PETERSON, P.A., WADSWORTH, S.C., COUTURE, K.K., PENNINGTON, S.E., STGEORGE, J.A., GOODING, L.R., and SMITH, A.E. (1997). Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8, 45-56
26. KAY, M.A., LI, Q., LIU, T.J., LELAND, F., TOMAN, C., FINEGOLD, M., and WOO, S.L. (1992). Hepatic gene therapy: Persistent expression of human alpha 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3, 641-647.
27. KNODELL, G., ISHAK, K.G., BLACK, W.C., CHEN, T.C., CRAIG, R., KAPLOWITZ, N., KIERNAN, W., and WOLLMAN, J. (1981). Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1(5), 431-435.
28. LI, Q., MURPHREE, S.S., WILLER, S.S., and FRENCH, B.A. (1998). Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar-syndrome type 1. Hum. Gene Ther. 9, 497-505.
29. LOSER, P., JENNINGS, G.S., STRAUSS, M., and SANDIG, V. (1998). Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver - involvement of NF-κ-B J. Virol. 72, 180-190.
30. LUSKY, M., CHRIST, M., RITTNER, K., DIETERLE, A., DREYER, D., MOUROT, B., SCHULTZ, H., STOECKEL, F., PAUIRANI, A., and MEHTALI, M. (1998). In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2a, or E1/E4 deleted. J. Virol. 72, 2022-2032.
31. McCLANE, S.J., HAMILTON, T.E., DEMATTEO, R.P., BURKE, C., and RAPER, S.E. (1997). Effect of adenoviral early genes and the host immune system on in vivo pancreatic gene transfer in the mouse. Pancreas 15, 236-245.
32. MEDGHALCHI, S., PADMANABHAN, R., and KETNER, G. (1997). Early region 4 modulates adenovirus dna replication by two genetically separable mechanisms. Virology 236, 8-17.
33. MICHOU, A.I., SANTORO, L., CHRIST, M., JULLIARD, V., PAVIRANI, A., and MEHTALI, M. (1997). Adenovirus-mediated gene transfer - influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4, 473-482.
34. MORRAL, N., ONEAL, W., ZHOU, H.S., LANGSTON, C., and BEAUDET, A. (1997). Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors -comparison of E2a wild type and E2a deleted vectors. Hum. Gene Ther. 8, 1275-1286.
35. MORSY, M.A., GU, M.C., ZHAO, J.Z., HOLDER, D.J., ROGERS, I.T., POUCH, W.J., MOTZEL, S.L., KLEIN, H.J., GUPTA, S.K., LIANG, X., TOTA, M.R., ROSENBLUM, C.I., and CASKEY, C.T. (1998). Leptin gene therapy and daily protein administration - a comparative study in the ob/ob mouse. Gene Ther. 5, 8-18.
36. MUHLHAUSER, J., JONES, M., YMADA, I., CIRIELLI, C., LEMARCHAND, P., GLOE, T.R., BEWIG, B., SIGNORETTI, S., CRYSTAL, R.G., and CAPOGROSSI, M.C., (1996). Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3, 145-153.
37. PARKER, E.J., BOTTING, C.H., WEBSTER, A., and HAY, R.T. (1998). Adenovirus DNA polymerase - domain organisation and interaction with preterminal protein. Nucleic Acids Res. 26, 1240-1247.
38. PRONK, R., STUIVER, M.H., and VAN DER VLIET, P.C. (1992). Adenovirus DNA replication: The function of the covalently bound terminal protein. Chromosoma 102(Suppl.), S39-45.
39. SCHOWALTER, D.B., MEUSE, L., WILSON, C.B., LINSLEY, P.S., and KAY, M.A. (1997). Constitutive expression of murine CTLA4IG from a recombinant adenovirus vector results in prolonged transgene expression. Gene Ther. 4, 853-860.
40. SUZUKI, M., SINGH, R., MOORE, M.A.S., SONG, W.R., and CRYSTAL, R.G. (1998). Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes. Hum. Gene Ther. 9, 1223-1231.
41. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
42. VINCENT, N., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
43. WANG, Q., GREENBURG, G., BUNCH, D., PARSON, D., and FINER, M.H. (1997). Persistent transgene expression in mouse liver following in vivo gene transfer with a delta-E1/delta-E4 adenovirus vector. Gene Ther. 4, 393-400.
44. WOLFF, J.A., LUDTKE, J.J., ACSADI, G., WILLIAMS, P., and JANI, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369.
45. WORGALL, S., WOLFF, G., FALCKPEDERSEN, E., and CRYSTAL, R.G. (1997). Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8, 37-44.
46. XIAO, X.A., LI, J.A., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
47. YANG, L., LOCHMULLER, H., LUO, J., MASSIE, B., NALBANTOGLU, J., KARPATI, G., and PETROF, B.J. (1998). Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (mdx) mice. Gene Ther. 5, 369-379.